Top Tweets for #timeToxicity
@stage4kelly That’s a lot of #timetoxicity - if I lived closer, I’d offer to 🚙 chauffeur. ♥️ Drive safe to/from. 🤞🏻for good MRI results, & may Pembro + Cape be wickedly vicious on those cancer cells, while gentle on you, my friend!
Our junior @CULymphoma faculty Dr. @majorajay was featured @CUCancerCenter about his latest publication in @OncJournal on patient-reported #timetoxicity from bispecific antibodies in relapsed/refractory lymphomas. #lymsm #supponc
https://t.co/sKZ3AybmNG
The association between health care contact days, care experience, and out-of-pocket spending for older adult cancer survivors https://t.co/1LtFs4OYd8 @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #TimeToxicity #CareBurdens #CareManagement #CareExperience
#TimeToxicity is real, especially for those living with #MetastaticBreastCancer, where time itself can become collateral damage to cancer care.
@AMJohnston1315 captures this reality with honesty, nuance, & the lived experience so many in the #bcsm community will recognize. Worth the read 👇🏻
New blog post up — had to apply the study from a Live from Stage 4 episode to myself, with interesting results. Time toxicity is a real thing!
https://t.co/XcauNeodhP #bcsm
Important perspective from the patient (lived) experience 👇🏻👇🏻a 🧵from @stage4kelly
#bcsm
#ClinicalTrials
#PatientAdvocate
#metastaticbreastcancer
#TimeToxicity
#FinancialToxicity
#research
@JaniceTNBCmets I can attest to the 🕰️ burden, although I’ve been in P1 trials which are known to be more time intensive. Just getting to my 1st P1 trial required a 4 hr 🚙 , 1 way. The current trial requires 10-12 hrs of 🚙 & ✈️ each way. Visit days range from 3-8+ hours. For an oral drug 💊
VIKTORIA-1 is one worth watching at #ASCO26. I’ll be doing so from afar this year 🥺 (#fomo)
The data look interesting, & I’m always glad to see new options moving forward, but from the patient side none of these tx arms look easy. Weekly IV visits 🟰 #timetoxicity, IM fulvestrant isn’t pleasant, & alpelisib isn’t exactly known for being easy to tolerate. Efficacy matters, but so does the lived burden of getting the treatment.
#bcsm
#metastaticbreastcancer
🔥 A new challenger in the post-CDK4/6 setting.
The Phase 3 VIKTORIA-1 trial just delivered positive topline results, and the message is clear:
👉 Targeting one node of the PI3K pathway may not be enough anymore.
🧬 Gedatolisib goes broader, blocking the entire PI3K/AKT/mTOR pathway
📊 Both triplet and doublet regimens showed PFS improvement vs alpelisib-based therapy
⚠️ But full data? Still under embargo until ASCO 2026
The real questions now:
▪ Does triplet therapy justify CDK4/6 continuation?
▪ Can full pathway inhibition outperform single-target drugs?
▪ Will this change 2nd line standard of care?
📍 VIKTORIA-1 might not just add another option…
👉 it could redefine how we treat PIK3CA-mutant metastatic breast cancer
https://t.co/1z0XQSaUDL
@curijoey @ASCO
#BreastCancer #MetastaticBreastCancer #OncoDaily #PIK3CA #CDK46 #TargetedTherapy #PrecisionOncology #ASCO2026 #OncoDailyBreast
@TylerSbrt @DrewMoghanaki @NehaVapiwala The field is a bit scattered for nomenclature. Some argue that time toxicity & financial toxicity are not appropriate.
Arguments that #financialToxicity is not a strong enough term https://t.co/yRnJZmxab5
In a recent on #timeToxicity @JCOOP_ASCO
https://t.co/V8BhY30RPm
🕘 #TimeToxicity is not toxic to many patients with #cancer.
📖 Interviews detailed in @JCOOP_ASCO show many patients, caregivers and oncologists see the term “time toxicity” as too negative, and more neutral terms could help clinicians build more trust. https://t.co/XGpfB5XVMC
❓Is #TimeToxicity too negative?
Patients, caregivers and oncologists say “toxicity” could communicate judgement on #cancer care choices.
📹 Time commitment, time impact or time trade-off may be more “approachable.” @SamuelXStevens @csoncol @queensu
🔗 https://t.co/Gfmq7JfLvG
🕙 Time commitment. Time impact. Time trade-off.
Patients and caregivers offered multiple terms to replace #TimeToxicity, which can describe time spent on #cancer care negatively.
🗨️ “Patient-friendly terms” are needed. @SamuelXStevens @csoncol @queensu https://t.co/ImXIRWqoev
Australian Oncologist Perspectives on Time Toxicity - Sam Stevens
@queensu
https://t.co/j2xZZsqxOC
#OncoDaily #Oncology #Cancer #Health #Medicine #TimeToxicity #MedX #MedTwitter
@manjuggm @GIMedOnc This totally makes sense & pretty std in 🇨🇦 - offer pts the option to self-disconnect their 5FU infusor
- empowers pts, ⬇️#timetoxicity & improves system capacity
- we also offer community nursing disconnect if pts prefer
5.15am-at the hospital for petscan for surveillance. 6.40 am-paperwork, 8.30am-canula inserted &iam injected with the “dye”. 9.30am-i go in for petscan, 9.45am done…just another day in the life of a #CancerSurvivor. #TimeToxicity @kenconetwork @pinkheartcancer @uicc @oncodaily
Strongly recommend this prospective study from Indian colleagues reporting the #TimeToxicity of palliative chemo. Very tricky work I'm sure. Great 2 see TT mapped in non-HIC context + linked to practical/policy solutions. Another @credoworkshop success!
https://t.co/KRJ0JcgzAs
These are critical utilizations of #tech in #oncology. The #timetoxicity of #cancer treatments is draining. Innovative interventions that improve #quality and perception for patients pursuing #disease directed treatment is critical
@crisbergerot
@montypal
@jatwanikaran
@OncJournal
#TOeJC
🎮 Virtual Reality (VR) in Oncology
VR is making long chemo sessions easier!
Breast cancer patients using VR ⬇️ perceived duration, ⬆️ distraction & ⬆️tolerance, underestimating time by 23 minutes. #TOeJC https://t.co/dDaiC4wtsg
@realbowtiedoc @susanebates @crisbergerot @montypal @jatwanikaran @OncJournal Especially important when we consider #timetoxicity & #financialtoxicity of individuals living w/cancer as well as staffing shortages
Great to share our work on #timetoxicity with colleagues at @QueensSCRI and @csoncol, though I think the highlight was seeing my wife join the zoom call!
#ASCO25 exciting new data for KLK2 CD3 bi-specific #mCRPC low TRAE and improved #timetoxicity for patients @DrYukselUrun @DrChoueiri @neerajaiims
‼️ #ASCO25 simultaneous publication by @drmnstein et al:
Pasritamig in Metastatic Castration-Resistant Prostate Cancer. Read the full article: https://t.co/hQAWebRZmT #mCRPC
"Beyond the clinic: Comprehensive assessment of time burdens in cancer care."
The time spent on cancer related-care is vastly underestimated when capturing healthcare encounters only. Dr Rachel Vogel at #ASCO25 #timeToxicity
@drakhilkapoor1 A great option (now with strong supporting data) for these group of patients in earlier and later lines of treatment. Also avoids #financialtoxicity and #timetoxicity , the two burdens affecting the caregivers the most
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.6M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.2M followers
Taylor Swift
@taylorswift13
82.1M followers
Lady Gaga
@ladygaga
73.6M followers
Virat Kohli
@imvkohli
70.7M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.6M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers